文献速递核素与放射性配体治疗放射性药物与辐射防护

MIRD 第27号手册:MIRDcell V3,用于多细胞剂量学与生物效应建模的修订版软件工具

MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling.
PubMed 文献 · J Nucl Med · 2022-02-10

该手册介绍 MIRDcell 软件第3版(V3),其结合解析与蒙特卡罗方法对平面集落和多细胞团簇内放射性标记细胞进行剂量学与生物效应建模,并提供操作示例;V3 能有效重现多细胞球体对均匀与非均匀分布治疗性放射性药物的实验反应。

要点

  • MIRDcell V3 可对平面集落和多细胞团簇内放射性标记细胞进行剂量学与生物效应建模。
  • V3 新增径向依赖性活度分布、用户导入活度分布、团簇内冷区及复杂生物效应建模等功能。
  • V3 能有效重现多细胞球体对均匀与非均匀分布治疗性放射性药物的实验反应。

核心结论

  • MIRDcell 是一款多用途软件工具,可用于教育目的和放射性药物治疗设计。

研究设计与样本

  • 该手册描述 MIRD 委员会多年前首次发布的 MIRDcell 软件的新版本(V3)。
  • V3 使用解析与蒙特卡罗方法相结合,对平面集落和多细胞团簇内的放射性标记细胞进行剂量学与生物效应建模。
  • 提供操作示例以帮助用户学习 MIRDcell 的新旧功能,并测试其重现已发表肿瘤细胞球体对放射性药物治疗反应的能力。

主要发现

  • MIRDcell V3 能有效重现多细胞球体对均匀与非均匀分布治疗性放射性药物的实验反应。

关键数值与推荐

  • 新版本的主要能力包括径向依赖性活度分布、用户导入活度分布、团簇内冷区、考虑辐射类型与亚细胞分布的复杂生物效应建模,以及用于后续分析的丰富输出数据表。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiopharmaceutical therapy is growing rapidly. However, yet to be addressed is the implementation of methods to plan treatments for circulating tumor cells, disseminated tumor cells, and micrometastases. Given the capacity of radiopharmaceuticals to specifically target and kill single cells and multicellular clusters, a quality not available in chemotherapy and external-beam radiation therapy, it is important to develop dosimetry and bioeffect modeling tools that can inform radiopharmaceutical design and predict their effect on microscopic disease. This pamphlet describes a new version of MIRDcell, a software tool that was initially released by the MIRD committee several years ago. Methods: Version 3 (V3) of MIRDcell uses a combination of analytic and Monte Carlo methods to conduct dosimetry and bioeffect modeling for radiolabeled cells within planar colonies and multicellular clusters. A worked example is provided to assist users to learn old and new features of MIRDcell and test its capacity to recapitulate published responses of tumor cell spheroids to radiopharmaceutical treatments. Prominent capabilities of the new version include radially dependent activity distributions, user-imported activity distributions, cold regions within the cluster, complex bioeffect modeling that accounts for radiation type and subcellular distribution, and a rich table of output data for subsequent analysis. Results: MIRDcell V3 effectively reproduces experimental responses of multicellular spheroids to uniform and nonuniform distributions of therapeutic radiopharmaceuticals. Conclusion: MIRDcell is a versatile software tool that can be used for educational purposes and design of radiopharmaceutical therapies.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Katugampola S, Wang J, Rosen A, et al. MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling. J Nucl Med. 2022. PMID: 35145016. doi:10.2967/jnumed.121.263253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。